首页> 外文期刊>The Canadian journal of clinical pharmacology =: Journal canadien de pharmacologie clinique >The burden of prenatal exposure to alcohol: REVISED measurement of cost
【24h】

The burden of prenatal exposure to alcohol: REVISED measurement of cost

机译:产前暴露于酒精的负担:修订后的成本计量

获取原文
获取原文并翻译 | 示例
       

摘要

In Canada the incidence of Fetal Alcohol Spectrum Disorder (FASD) is estimated to be 1 in 100 live births. FASD is the leading cause of developmental and cognitive disabilities in Canada. Only one study has examined the cost of FASD in Canada. In that study we did not include prospective data for infants under the age of one year, costs for adults beyond 21 years or costs for individuals living in institutions. Objective To calculate a revised estimate of direct and indirect costs associated with FASD at the patient level. Methods Cross-sectional study design was used. Two-hundred and fifty (250) participants completed the study tool. Participants included caregivers of children, youth and adults, with FASD, from day of birth to 53 years, living in urban and rural communities throughout Canada participated. Participants completed the Health Services Utilization Inventory (HSUI). Key cost components were elicited: direct costs: medical, education, social services, out-of-pocket costs; and indirect costs: productivity losses. Total average costs per individual with FASD were calculated by summing the costs for each in each cost component, and dividing by the sample size. Costs were extrapolated to one year. A stepwise multiple regression analysis was used to identify significant determinants of costs and to calculate the adjusted annual costs associated with FASD. Results Total adjusted annual costs associated with FASD at the individual level was $21,642 (95% CI, $19,842; $24,041), compared to $14,342 (95% CI, $12,986; $15,698) in the first study. Severity of the individual's condition, age, and relationship of the individual to the caregiver (biological, adoptive, foster) were significant determinants of costs (p < 0.001). Cost of FASD annually to Canada of those from day of birth to 53 years old, was $5.3 billion (95% CI, $4.12 billion; $6.4 billion). Conclusions Study results demonstrated the cost burden of FASD in Canada was profound. Inclusion of infants aged 0 to 1 years, adults beyond the age of 21 years and costs associated with residing in institutions provided a more accurate estimate of the costs of FASD. Implications for practice, policy, and research are discussed.
机译:在加拿大,胎儿酒精频谱疾病(FASD)的发病率估计为每100例活产中有1例。 FASD是加拿大发展和认知障碍的主要原因。只有一项研究检查了加拿大FASD的成本。在该研究中,我们未包括1岁以下婴儿的前瞻性数据,21岁以上成年人的费用或居住在机构中的个人的费用。目的计算患者一级与FASD相关的直接和间接费用的修订估算。方法采用横断面研究设计。百五十二(250)名参与者完成了该研究工具。参加者包括FASD的儿童,青年和成人,从出生之日到53岁,住在加拿大各地的城市和农村社区。参加者填写了《健康服务利用清单》(HSUI)。得出了主要的费用组成部分:直接费用:医疗,教育,社会服务,自付费用;和间接成本:生产力损失。通过将每个成本组成部分中每个人的成本相加,再除以样本量,得出具有FASD的每个人的平均总成本。费用被推断为一年。使用逐步多元回归分析来确定成本的重要决定因素,并计算与FASD相关的调整后的年度成本。结果个人一级与FASD相关的调整后的年度总成本为21,642美元(95%CI,19,842美元; 24,041美元),而第一项研究为14,342美元(95%CI,12,986美元; 15,698美元)。个人病情的严重程度,年龄以及个人与护理人员的关系(生物学,收养,寄养)是决定费用的重要因素(p <0.001)。从出生之日到53岁,FASD每年在加拿大的费用为53亿加元(95%CI,41.2亿加元; 64亿加元)。结论研究结果表明,加拿大FASD的成本负担沉重。包括0至1岁的婴儿,21岁以上的成年人以及与在机构中居住相关的费用,可以更准确地估算FASD的费用。讨论了对实践,政策和研究的影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号